You are using an older browser version. Please use a supported version for the best MSN experience.

Tough to find something good in AbbVie-Allergan deal, strategist says

John Rountree, partner at Novasecta, discusses U.S. drugmaker AbbVie's $63 billion acquisition of Allergan.
image beaconimage beaconimage beacon